SBMA as a model of polyglutamine diseases: generation of a suitable cell system to study the post-transcriptional modifications of mutant androgen receptor and to discover potential therapeutic drugs

Project Information

PolyQ mutant AR/SBMA

Grant agreement ID: 300723

Project closed

Start date 1 April 2013

End date 31 March 2015

Funded under

• Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)

Total cost € 178 760,70

EU contribution € 178 760,70

Coordinated by

FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIA
Italy